The company reported third-quarter gains of 24 percent for hip implants, to $6.8 million; 4 percent for knee implants, to $17.3 million; and 7 percent for biologic and spine, to $6.5 million.
Total revenue for the first nine months of 2009 rose 6 percent, to $129 million, over the same period last year.
Read Exactech’s release on third-quarter sales.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
